Our History

BioDot Abstract Background

Since 1994, BioDot has pioneered the diagnostics and dispensing industries. Directly responsible for billions of diagnostic tests every year, BioDot is also a trusted partner to more than 2,000 manufacturers and research organizations with systems in over 60 countries all over the world.

BioDot, Inc., founded by Dr. Thomas Tisone and Michael Surmanian in 1994, entered the diagnostics laboratory and manufacturing market providing automation and liquid handling systems for lateral flow tests and POC devices.

1994
Timeline
1994

BioDot, Inc., founded by Dr. Thomas Tisone and Michael Surmanian in 1994, entered the diagnostics laboratory and manufacturing market providing automation and liquid handling systems for lateral flow tests and POC devices.

19941994

Cartesian Technologies is formed to apply BioDot dispensing technologies to the life science market. The cross license grants exclusivity in the life sciences market to Cartesian Technologies.

1996
Timeline
1996

Cartesian Technologies is formed to apply BioDot dispensing technologies to the life science market. The cross license grants exclusivity in the life sciences market to Cartesian Technologies.

19961996

Schleicher & Schuell, a partner in the Lateral Flow Workshop and a membrane provider for lateral flow tests, invests in BioDot.

1996
Timeline
1996

Schleicher & Schuell, a partner in the Lateral Flow Workshop and a membrane provider for lateral flow tests, invests in BioDot.

19961996

In 1996, BioDot held its first lateral Flow Workshop. The workshop continues to be offered annually and teaches the nuances of developing and manufacturing lateral flow devices to a global audience.

1996
Timeline
1996

In 1996, BioDot held its first lateral Flow Workshop. The workshop continues to be offered annually and teaches the nuances of developing and manufacturing lateral flow devices to a global audience.

19961996

BioDot received its second dispensing technology patent.

1998
Timeline
1998

BioDot received its second dispensing technology patent.

19981998

One Step One Solution, an in-house assay development and training for lateral flow tests was launched.

2000
Timeline
2000

One Step One Solution, an in-house assay development and training for lateral flow tests was launched.

20002000

Genomic Solutions acquires Cartesian Technologies.

2001
Timeline
2001

Genomic Solutions acquires Cartesian Technologies.

20012001

BioDot, Inc. expands by acquiring BioDot Ltd, a UK company.

2001
Timeline
2001

BioDot, Inc. expands by acquiring BioDot Ltd, a UK company.

20012001

BioDot acquires Entevis low mass powder dispensing.

2006
Timeline
2006

BioDot acquires Entevis low mass powder dispensing.

20062006

BioDot, Inc. establishes a legal entity in Shanghai, China

2010
Timeline
2010

BioDot, Inc. establishes a legal entity in Shanghai, China

20102010

BioDot, Inc. regains access to the life science market; exclusivity with Cartesian Technologies dissolved.

2014
Timeline
2014

BioDot, Inc. regains access to the life science market; exclusivity with Cartesian Technologies dissolved.

20142014

Alliance with Symbolics developing technology for multiplex lateral flow devices.

2016
Timeline
2016

Alliance with Symbolics developing technology for multiplex lateral flow devices.

20162016

Alliance with ADS for promotion and distribution in the US and Europe of BioDot's CellWriter platform for cytogenetic applications.

2016
Timeline
2016

Alliance with ADS for promotion and distribution in the US and Europe of BioDot's CellWriter platform for cytogenetic applications.

20162016

Shipped 5000th System.

2018
Timeline
2018

Shipped 5000th System.

20182018

29th Patent Issued to BioDot.

2019
Timeline
2019

29th Patent Issued to BioDot.

20192019

CellWriter S use model is introduced.

2019
Timeline
2019

CellWriter S use model is introduced.

20192019

BioDot acquired by Artemis.

2020
Timeline
2020

BioDot acquired by Artemis.

20202020

ATS Automation announces plans to acquire BioDot.

2021
Timeline
2021

ATS Automation announces plans to acquire BioDot.

20212021
BioDot Dot